Important Announcement Annual Training Program in Immnohaematology... Read More

r>

Sr.No Particulars Vol. & No. Months Year
1 Discrepancies in ABO grouping XIV (1) Jan-Feb 1983
2 Data analysis of HBsAg testing workshop XIV (2) Mar-Apr 1983
3 Cell surface marker studies using monoclonal antibodies XIV (3) May-June 1983
4 Atypical blood group antibodies in blood group transfusion practice XIV (4) July-Aug 1983
5 2 nd HLA workshop on serum screening quality control. XV (5) Sept-Oct 1983
6 Application of cell separator machines XV (6) Nov-Dec 1983
7 Distribution of some genetic markers with special reference to Western India. XV (1) Jan-Feb 1984
8 HLA, Biological anthropology and India. XV (2) Mar-Apr 1984
9 Immunohaematological aspects of the complement system. XV (3) May-June 1984
10 Profile of immune response in iron deficiency system. XV (4) July-Aug 1984
11 Impact of the HLA system on immunogenetic research. XV (5) Sep-Oct 1984
12 Recent concepts in management of Rh haemolytic disease of the newborn. XV (6) Nov-Dec 1984
13 Human blood XVI (1) Jan-Feb 1985
14 Preparation and function of platelet components made in glass bottles. XVI (2) Mar-Apr 1985
15 Outline of biochemical changes of blood coagulation and coagulation disorders XVI (3) May-June 1985
16 Red cell serology in blood bank: an excercise in quality control XVI (4) July-Aug 1985
17 Immunofluorescent techniques in immunohaematology XVI (5) Sep-Oct 1985
18 Preservation of red cells in pilot tubes in blood banks. XVI (6) Nov-Dec 1985
19 Platelet transfusion and thrombocytopenic haemorrhagic disorders XVII (1) Jan-Feb 1986
20 Hodgkin's disease: historical perspective current status and future directions XVII (2) Mar-Apr 1986
21 Prenatal diagnosis of hemoglobinopathies XVII (3) May-Jun 1986
22 Acquired immune deficiency syndrome,(AIDS) its impact on blood transfusion services XVII (4) Jul – Aug 1986
23 Immunoblotting in Immunohaematology XVII (5) Sept-Oct 1986
24 ELISA Today XVII (6) Nov-Dec 1986
25 Genetic parameters: Biologic and epidemiologic significance XVIII (1) Jan-Feb 1987
26 Application of recombinant DNA technology for gene mapping of immunoglobulins XVIII (2) Mar-Apr 1987
27 C1q the first complement component -A review XVIII (3) May-June 1987
28 Chemistry of FVIII molecule XVIII (4) July-Aug 1987
29 Genetics and epidemiology of Sickle cell anemia in India XIX (1) Jan-Feb 1988
30 Intravenous immunoglobulin (IVIG) therapy – an alternate approach in the treatment of Idiopathic Thrombocytopenic Purpura (ITP) XIX (2) Mar-April 1988
31 The red cell membrane and it's vesiculation XIX (3) May-Jun 1988
32 Structure and genetic aspects of the HLA systems XIX (4) July-Aug 1988
33 Institute of Immunohaematology – referral services XIX (5) Sep-Oct 1988
34 Neonatal thrombocytopenia XIX (6) Nov-Dec 1988
35 Recent developments in transfusion medicine (The first Dr. H. M. Bhatia Memorial Oration) XX (1) Jan-Feb 1989
36 Community control of β-thalassemia XX (2) Mar-Apr 1989
37 Antibody dependent cell mediated phagocytosis and cytolysis XX (3) May-June 1989
38 The H antigen of the ABO blood group system XX (4) Jul-Aug 1989
39 AIDS and HIV infection: An Epidemiological overview XX (5) Sep-Oct 1989
40 Health education in sickle cell disease XX (6) XX (6) 1989
41 1)Studies on some aspects of the HLA system
2) HLA studies at the Cancer Research Institute (The Second Dr. H.M.Bhatia Memorial Oration)
XXI (1) Jan-Mar 1990
42 Preliminary report of blood component therapy (CT) experience at K.E.M. blood bank XXI (2) Apr- June 1990
43 Monoclonal antibodies in Hematology : Some less known facts XXI (3) July-Sept 1990
44 World congress on AIDS – Some highlights and update XXI (4) Oct-Dec 1990
45 A report on blood banking in India XXII (1) Jan-Mar 1991
46 Erythrocytes G6PD deficiency and its variants in West Bengal (The IIIrd Dr. H. M.Bhatia memorial oration) XXII (2) Apr-Jun 1991
47 Genetic red cell defects and malaria XXII(3-4) July-Dec 1991
48 Highlights of the XVIth Annual conference of the Bombay Haematology group (BHG) XXIII (1) Jan-Feb 1992
49 Molecular approaches to the detection of agents in persistent viral infections (The IV Dr.H.M.Bhatia Memorial Oration) XXIII (2) Mar-Apr 1992
50 Quality assurance in blood bank XXIII (3) May-Jun 1992
51 Preventive Hematology XXIII (4) July-Aug 1992
52 Autologus Transfusion XXIII (5) Sep-Oct 1992
53 Hematopoietic growth factors : Colony stimulating factors XXIII (6) Nov-Dec 1992
54 Glucose-6- Phosphate Dehydrogenase deficiency and its variants in India ( The V Dr.H.M.Bhatia Memorial Oration) XXIV (1-3) Jan-Jun 1993
55 The Anti-Idiotype network in systemic lupus erythematosus – A Review XXIV (4) Jul-Sept 1993
56 Recent advances in the management of Rh Hemolytic disease of the newborn (HDN) XXIV (5) Oct-Dec 1993
57 Blood transfusion (Red Cell) practices and policy for the Neonate XXV (1) Jan-Apr 1994
58 Apoptosis XXV (2) May-Aug 1994
59 The Haemopoietic progenitor cell XXV (3) Sept-Dec 1994
60 Current concepts in the immunology of allograft rejection XXVI (1) Jan-Apr 1995
61 Megaloblastosis, a morphologic expression of molecular derangementsin DNA and histone biosynthesis (The VI Dr.H.M.Bhatia Memorial Oration) XXVI (2&3) May-Dec 1995
62 Pretransplant blood transfusions in renal transplantation—Are They Beneficial? XXVII (1) Jan-Jun 1996
63 Cell Adhesion molecules in Haemopoiesis XXVII (2) Jul-Dec 1996
64 Bone marrow transplantation for thalassemia (The IX Dr.H.M.Bhatia Memorial Oration) XXVIII (1) Jan-June 1997
65 Chromosomal changes in acute leukemia XXVIII (2) July-Dec 1997
66 An overview of the blood programme in India and the need for revamping (The X Dr.H.M.Bhatia Memorial Oration) XXIX (1) Jan-April 1998
67 Donor selection for allogeneic bone marrow transplantation XXIX (2) May-Aug 1998
68 Prevention of Rh alloimmunization and management of Rh (D) haemolytic disease of the newborn by Intrauterine transfusion XXIX (3) Sept-Dec 1998
69 Progress in Technology for detection of mutations in hematological disorders XXX (1) Jan-April 1999
70 Bone Marrow density study in Patients with Thalassemia Major- A Preliminary Evaluation (The XI Dr.H.M.Bhatia Memorial Oration) XXX (2) May-Aug 1999
71 Hemophilia- From diagnosis to prevention XXX (3) Sept-Dec 1999
72 Health Problems of Tribal Population Groups from the State of Maharashtra (The XII Dr.H.M.Bhatia Memorial Oration) XXXI (1) Jan-Apr 2000
73 Resolving problems in pre transfusion investigations in blood group serology XXXI (3) Sept-Dec 2000
74 Allogenic bone marrow transplantation : looking back and planning ahead (The XIII Dr.H.M.Bhatia Memorial Oration) XXXII (1) Jan- April 2001
75 ANCA-Anti-Neutrophil Cytoplasmic Antibodies and their role in vasculitis associated kidney disorders XXXII (3) May-Aug 2001
76 Monoclonal antibodies – An overview XXXII (3) Sept-Dec 2001
77 My Experiences from Blood Components to Fractionation at KEM Hospital, Mumbai and SGPGIMS, Lucknow.(The XIV Dr.H.M.Bhatia Memorial Oration) XXXIII (1) Jan-Apr 2002
78 Air Travel & Deep Vein Thrombosis XXXIII (2) May-Aug 2002
79 Diagnostic assays for detection of HIV infection XXXIII (3) Sept-Dec 2002
80 Indian and genetic diversity in the genomic era: implications in health & disease (The XV Dr.H.M.Bhatia Memorial Oration) XXXIII (2) Jan-Apr 2003
81 Molecular genetics of sickle cell disease : an overview XXXIV (2) May-Aug 2003
82 Umbilical cord blood: biology of hematopoietic stem cells and their applications XXXIV (3) Sept-Dec 2003
83 Current status of understanding biology and management of chronic myeloid leukemia (The XVI Dr.H.M.Bhatia Memorial Oration) XXXV (1) Jan-Apr 2004
84 Concepts of confocal microscopy XXXV (2) May-Aug 2004
85 Fetal hemoglobin levels in adults XXXV (3) Sept-Dec 2004
86 Strategies for ensuring safe and blood products (The XVII Dr.H M Bhatia memorial oration) XXXVI (1) Jan-April 2005
87 Human platelet specific antigens and neonatal alloimmune thrombocytopenic purpura (NAITP) XXXVI (2) May-Aug 2005
88 Immunodiagnosis of some rheumatic and autoimmune diseases : An overview XXXVI (2) Sept-Dec 2005
89 Hereditary hemolytic anemia due to Pyruvate kinase deficiency (The XVIII Dr. H M Bhatia Memorial Oration) XXXVII (1) Jan-April 2006
90 Non invasive prenatal diagnosis – A Review XXXVII (2) May-Aug 2006
91 Arrray comparative genomic hybridization - An efficient tool for genome analysis XXXVII (3) Sept-Dec 2006
92 Coagulation disorders seen through the window of molecular biology XXXVIII (1) Jan-Apr 2007
93 The complexities of the ABO blood group system (past & present) XXXVIII (2) May-Aug 2007
94 Human red cell pyruvate kinase (PK) deficiency XXXVIII (3) Sep-Dec 2007
95 a) Dr. Kanjaksha Ghosh, Institute of Immunohematology (IIH) becomes National Institute of Immunohematology (NIIH)
b) Maya Gupta, Manisha Madkaikar, Recent Trends in diagnosis of Paroxysmal nocturnal haemoglobinuria
XXXIX (1) Jan-Apr 2008
96 Dr. V. Babu Rao, Genetic and Molecular pathology of Fanconi Anemia XXXIX (2) May-Aug 2008
97 Immunogenetics of ANCA associated vasculitis (AAV) review Vol. XXXIX(3) Sept-Dec 2008
98 Dr. H.M. Bhatia Oration- The Hemoglobinopathies-Thalassemia and Sickle Cell Disease: Paths of Progress- David G. Nathan (President Emeritus, Dana-Farber Cancer Institute, Boston USA. Vol.XXXX(1) Jan-Apr 2009
99 The Use of Hydroxyurea in Sickle Cell Disease Vol. XXXX(2) May-Aug 2009
100 Haemophagocytic Lymphohistiocytosis: Clinical features, pathogenesis and treatment Vol.XXXX(3) Sep-Dec 2009
101 Dr. H.M. Bhatia Oration- Some lessons from the interface of Genetics and Hematology Vol. XXXXI(1) Jan-Apr 2010
102 Rhesus blood group system- structure and function Vol.XXXXI(2) May-Aug 2010
103 History of National Institute of Immunohaematology (ICMR)-Ghosh K 42(1-3) Jan-Dec 2011
104 Matrix Metalloproteinases (MMPS)in Human Health and Diseases- Chaudhary AK Rapid Flow Cytometric test using EOSIN-5' – Maleimide dye for the diagnosis of Red Blood Cell membrane disorders- Kedar PS 43(1-2) Jan-Aug 2012
105 Red Cell Membrane Protein Disorders- Warang P A two tube assay for detecting mild to moderate deficiency of Factor XIII- Shanbhag S 43(3) Sep-Dec 2012
106 Cytogenetic and molecular changes in myelodysplastic syndromes- Korgaonkar SA A Novel elisa for diagnosis of Glanzmann's thrombasthenia and the heterozygote carriers- Lobo V 44(1) Jan-Apr 2013
107 Contribution of National Institute of Immunohaematology (NIIH) on Tribal Health Research- Mukherjee MB 44(2) May-Aug 2013
108 Celluler signaling using multi parametric flow cytometry: a learner's guide- Garg S 44(3) Sep-Dec 2013
109 Imatinib resistant chronic myeloid leukemia and therapeutic approach- Vaidya S 45(1) Jan-Apr 2014
110 Neonatal screening and natural history of sickle cell disease- Upadhye D 45(2) May-Aug 2014
111 Circulating cell-derived procoagulant microparticles in women with unexplained recurrent pregnancy loss- Patil R 45(3) Sep-Dec 2014
112 The genetic basis of hyperbilirubinemia- Chiddawar A 46(1) Jan-Apr 2015
113 Warfarin pharmacogenetics: Implications for personalized medicine - Tejasvita Gaikwad 46(2) May-Aug 2015
114 Neonatal Sepsis: An Overview - Martin S 46(3) Sep-Dec 2015
115 Molecular genotyping of blood group antigens 47(1) Jan-April 2016
116 Hepatitis C Infection : Prevalence, Diagnosis and Treatment - An Overview - Priya Yabaji 47(2) May-Aug 2016
117 Fanconi anemia: A multispectrum disease - Avani Solanki 47(3) Sep-Dec 2016
118 Adipokines: the new players of inflammatory response in Systemic Lupus Erythematosus - Durga Chougule 48(1) Jan-April 2017